Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common stock, par value $0.00001 per share
-
Shares outstanding
-
52,942,731
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
42,241,228
-
Shares change
-
+2,325,865
-
Total reported value, excl. options
-
$1,442,956,792
-
Value change
-
+$80,038,413
-
Number of buys
-
56
-
Number of sells
-
-27
-
Price
-
$34.16
Significant Holders of PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) as of Q2 2021
98 filings reported holding PMVP - PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share as of Q2 2021.
PMV Pharmaceuticals, Inc. - Common stock, par value $0.00001 per share (PMVP) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,241,228 shares
of 52,942,731 outstanding shares and own 79.79% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7,330,423 shares), INTERWEST VENTURE MANAGEMENT CO (4,969,911 shares), Euclidean Capital LLC (3,908,677 shares), BOXER CAPITAL, LLC (2,268,236 shares), VANGUARD GROUP INC (2,241,711 shares), BlackRock Inc. (1,918,134 shares), Avoro Capital Advisors LLC (1,825,000 shares), VIKING GLOBAL INVESTORS LP (1,790,284 shares), RA CAPITAL MANAGEMENT, L.P. (1,710,265 shares), and JPMORGAN CHASE & CO (1,643,064 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.